296 related articles for article (PubMed ID: 36675186)
21. Transcriptome-wide N6-methyladenosine (m6A) methylation profiling of long non-coding RNAs in ovarian endometriosis.
Liu H; Liang J; Dai X; Peng Y; Xiong W; Zhang L; Li X; Li W; Liu K; Bi S; Wang X; Zhang W; Liu Y
Genomics; 2024 Mar; 116(2):110803. PubMed ID: 38290592
[TBL] [Abstract][Full Text] [Related]
22. N6-methyladenosine modulation classes and immune microenvironment regulation in ischemic stroke.
Tao H; Dong L; Li L
Front Mol Neurosci; 2022; 15():1013076. PubMed ID: 36762188
[TBL] [Abstract][Full Text] [Related]
23. Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis.
Li S; Liu H; Ruan Z; Guo R; Sun C; Tang Y; Huang X; Gao T; Hao S; Li H; Song N; Su Y; Ning F; Li Z; Chang T
J Transl Med; 2023 Mar; 21(1):166. PubMed ID: 36864526
[TBL] [Abstract][Full Text] [Related]
24. Function and prognostic value of N6-methyladenosine-modified RNAs in lung adenocarcinoma.
Liu J; Zheng Z; Zhong J
J Gene Med; 2023 Jan; 25(1):e3454. PubMed ID: 36282144
[TBL] [Abstract][Full Text] [Related]
25. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
[TBL] [Abstract][Full Text] [Related]
26. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
[TBL] [Abstract][Full Text] [Related]
27. Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer.
Liu J; Zhang W; Wang J; Lv Z; Xia H; Zhang Z; Zhang Y; Wang J
J Cancer Res Clin Oncol; 2023 May; 149(5):1969-1983. PubMed ID: 35731271
[TBL] [Abstract][Full Text] [Related]
28. m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of coronary heart disease.
Li Z; Song Y; Wang M; Shen R; Qin K; Zhang Y; Jiang T; Chi Y
Front Cardiovasc Med; 2022; 9():905737. PubMed ID: 36093132
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
Yu ZL; Zhu ZM
Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
[TBL] [Abstract][Full Text] [Related]
30. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
31. Molecular subtype identification and predictive power of N6-methyladenosine regulator in unexplained recurrent pregnancy loss.
Huo J; Chen Q; Zhang Y; Li N; Fu Z; Ma N; Zheng N; Cui N; Li L
Front Genet; 2022; 13():925652. PubMed ID: 36118846
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value and immune infiltration characterization of YTHDF2 as a critical m6A regulator in osteoarthritic synovitis.
Bian A; Wang C; Zhang H; Yan Y; Zhang L; Cheng W
J Orthop Surg Res; 2023 Jul; 18(1):535. PubMed ID: 37496062
[TBL] [Abstract][Full Text] [Related]
33. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K
Front Immunol; 2021; 12():637933. PubMed ID: 33746977
[TBL] [Abstract][Full Text] [Related]
34. Characterization of ligamentum flavum hypertrophy based on m6A RNA methylation modification and the immune microenvironment.
He Z; Zhu Z; Tang T; Guo P; Gao M; Li B; Nguyen TCT; Chen H; Liu X; Zhou Z; Liu S
Am J Transl Res; 2022; 14(12):8800-8827. PubMed ID: 36628248
[TBL] [Abstract][Full Text] [Related]
35. A ten N6-methyladenosine-related long non-coding RNAs signature predicts prognosis of triple-negative breast cancer.
Wu J; Cai Y; Zhao G; Li M
J Clin Lab Anal; 2021 Jun; 35(6):e23779. PubMed ID: 33934391
[TBL] [Abstract][Full Text] [Related]
36. M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer.
Liu X; Ma C; Liu H; Sun Z; Luo J
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2803-2814. PubMed ID: 35596010
[TBL] [Abstract][Full Text] [Related]
37. Microenvironment modulation by key regulators of RNA N6-methyladenosine modification in respiratory allergic diseases.
Wang Y; Wang J; Yan Z; Liu S; Xu W
BMC Pulm Med; 2023 Jun; 23(1):210. PubMed ID: 37328853
[TBL] [Abstract][Full Text] [Related]
38. Dynamic N6-methyladenosine modification of lncRNA modulated by METTL3 during bacterial disease development in an echinoderm.
Zhang S; Shao Y; Li D; Li C
Fish Shellfish Immunol; 2022 May; 124():497-504. PubMed ID: 35483599
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of METTL3/m6A/miR126 promotes the migration and invasion of endometrial stromal cells in endometriosis†.
Li X; Xiong W; Long X; Dai X; Peng Y; Xu Y; Zhang Z; Zhang L; Liu Y
Biol Reprod; 2021 Nov; 105(5):1221-1233. PubMed ID: 34382070
[TBL] [Abstract][Full Text] [Related]
40. m6A methyltransferase METTL3 inhibits endometriosis by regulating alternative splicing of MIR17HG.
Li Q; Yang L; Zhang F; Liu J; Jiang M; Chen Y; Ren C
Reproduction; 2023 Feb; 165(2):197-208. PubMed ID: 36445237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
